Centogene N.V. logo
Centogene N.V. CNTG
report update icon

Quarterly report 2023-Q4
added 06-27-2026

Centogene N.V. Net Income | CNTG

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Centogene N.V.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-35.5 M -31.8 M -46.2 M -22 M -20.9 M -11.3 M -5.48 M -5.36 M - - - - -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
-5.36 M -46.2 M -22.3 M

Quarterly Net Income Centogene N.V.

2023-Q4 2023-Q2 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-35.5 M -24.5 M -31.8 M - - -6.48 M -46.2 M -21.6 M -8.02 M -4.89 M -22 M -5.64 M -10.4 M -8.74 M - -4.28 M -6.28 M -5.28 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum Minimum Average
-4.28 M -46.2 M -16.1 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Diagnostics research industry

Issuer Net Income Price % 24h Market Cap Country
Enzo Biochem Enzo Biochem
ENZ
-26.1 M - -8.98 % $ 14.8 K usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
-33.5 M - 5.66 % $ 22.7 M britainBritain
DexCom DexCom
DXCM
836 M $ 82.53 0.6 % $ 32.2 B usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
42.5 M - - $ 1.49 B usaUSA
Heska Corporation Heska Corporation
HSKA
-19.9 M - - $ 1.31 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-50 M - -61.36 % $ 2.46 M usaUSA
Celcuity Celcuity
CELC
-177 M $ 55.51 -3.86 % $ 2.6 B usaUSA
T2 Biosystems T2 Biosystems
TTOO
-50.1 M - -39.35 % $ 313 K usaUSA
Syneos Health Syneos Health
SYNH
266 M - - $ 4.46 B usaUSA
Biocept Biocept
BIOC
-32.1 M - -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
-99.8 M - - $ 21.2 M usaUSA
Quotient Limited Quotient Limited
QTNT
-125 M - -11.32 % $ 1.1 M schweizSchweiz
DermTech DermTech
DMTK
-101 M - -11.32 % $ 2.94 M usaUSA
Surmodics Surmodics
SRDX
-11.5 M - - $ 608 M usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
2.92 M $ 9.02 -1.04 % $ 306 M israelIsrael
Akumin Akumin
AKU
-157 M - -17.87 % $ 25.9 M canadaCanada
Psychemedics Corporation Psychemedics Corporation
PMD
-1.86 M - -1.84 % $ 15.3 M usaUSA
Danaher Corporation Danaher Corporation
DHR
3.61 B $ 228.43 1.18 % $ 163 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
-23.3 M - 0.22 % $ 16.8 M usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
-12.9 M - -34.28 % $ 263 K israelIsrael
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
-21.6 M - -20.0 % $ 1.06 M usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
-10.9 M $ 2.72 1.87 % $ 88.3 K usaUSA
Biodesix Biodesix
BDSX
-35.3 M $ 8.42 -5.18 % $ 63.6 M usaUSA
Agilent Technologies Agilent Technologies
A
1.3 B $ 176.32 2.38 % $ 50.1 B usaUSA
BioNano Genomics BioNano Genomics
BNGO
-26.4 M $ 0.98 3.13 % $ 5.34 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
-55.3 M $ 12.85 2.8 % $ 135 M chinaChina
Bioventus Bioventus
BVS
22.7 M $ 10.64 0.38 % $ 709 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
992 M $ 259.18 1.1 % $ 28.8 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
-144 M $ 333.37 0.36 % $ 16.5 B usaUSA
Guardant Health Guardant Health
GH
-416 M $ 145.11 1.28 % $ 18.2 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
-24.2 M $ 33.41 1.3 % $ 968 M usaUSA
Illumina Illumina
ILMN
850 M $ 209.18 3.24 % $ 32.4 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
1.36 B $ 257.93 0.13 % $ 44.3 B usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
877 M $ 370.49 0.61 % $ 30.8 B usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
1.06 B $ 700.79 1.53 % $ 56.4 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
451 M $ 647.03 -0.93 % $ 18.7 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
869 M $ 1 734.36 1.25 % $ 35.7 B schweizSchweiz
Natera Natera
NTRA
-208 M $ 286.77 -0.25 % $ 39.2 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
234 M $ 102.03 0.23 % $ 6.89 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
-60.5 M $ 25.14 3.84 % $ 774 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
-21.4 M $ 74.4 -0.21 % $ 3.96 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
-1.81 M - - $ 562 M britainBritain
Biomerica Biomerica
BMRA
-3.78 M $ 1.15 -6.88 % $ 3.35 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
24.6 M $ 5.44 -9.42 % $ 24.1 M usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
-53 M - 1.08 % $ 308 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
229 M $ 194.96 -0.03 % $ 15.3 B irlandaIrlanda
Senseonics Holdings Senseonics Holdings
SENS
-69.1 M $ 9.76 -3.99 % $ 407 M usaUSA
Sotera Health Company Sotera Health Company
SHC
77.9 M $ 16.27 1.34 % $ 4.62 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
-46.9 M $ 0.2 1.99 % $ 266 K usaUSA
Precipio Precipio
PRPO
-363 K $ 18.8 -1.93 % $ 30.2 M usaUSA